Skip to main content
Premium Trial:

Request an Annual Quote

HGS to Offer 8 Million New Shares

NEW YORK, Oct 19 – Human Genome Sciences said Thursday that it would issue a public offering of 8,000,000 additional shares of its common stock, plus up to 1,200,000 shares to cover over-allotments, if any.

HGS expects to use the money raised from this offering for drug development, patent coverage, manufacturing facilities, acquisitions, as well as for general corporate purposes.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.